NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Diagnostics & Research · USD

Sotera Health Company (SHC) Stock Analysis

Sotera Health Company (SHC) is a Diagnostics & Research stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

SHC

$17.77

−$0.16 (−0.89%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SHC with… →

SHC Key Statistics

As of Oct 21, 2026
Trading
Open
$17.93
Previous Close
$17.93
Day's Range
17.75–18.16
52-Week Range
13.09–19.85
Volume
2.72M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.86
Valuation
Market Cap
$5.07B
P/E Ratio
31.18
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
16.53
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.31
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
4.17
EPS (ttm)Profit attributable to each share over the last twelve months.
0.57
Financials (FY)
Revenue (FY)
$1.16B+5.74%
Net Income (FY)
$77.95M+75.57%
Profit marginThe share of revenue left as profit after all costs and taxes.
13.44%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
285.37M
1-Year Return
+6.92%
Dividend and dates
Earnings Date
November 3, 2026
Avg Volume
2.38M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, SHC closed at $17.77, +6.92% over 1 year.

Sotera Health Company (SHC) has a market capitalization of $5.07B.

In fiscal 2025, SHC reported revenue of $1.16B.

SHC Stock Return by Calendar Year

Sotera Health Company (SHC) return since Nov 2020: what $10,000 became

1 year
$10,000 $10,692
+6.92%
5 years
$10,000 $6,819
−31.81%
Since Nov 2020
$10,000 $7,080
−29.20%

If you had invested $10,000 in Sotera Health Company (SHC) at the close on November 20, 2020, the earliest close on record here, it would have been worth $7,080 at the close on October 21, 2026: −29.20% in total, −5.67% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+0.74%
2025+28.95%
2024−18.81%
2023+102.28%
2022−64.63%
2021−14.18%
2020 (partial year)+9.32%

As of October 21, 2026.

SHC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.16B$77.95M6.7%
2024$1.10B$44.40M4.0%
2023$1.05B$51.38M4.9%
2022$1.00B−$233.57M−23.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.16B$645.53M$362.03M$77.95M6.7%
2024$1.10B$602.30M$297.63M$44.40M4.0%
2023$1.05B$577.16M$276.69M$51.38M4.9%
2022$1.00B$557.00M$248.35M−$233.57M−23.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SHC Valuation vs Diagnostics & Research Median

Median of 45 stocks
MetricSHCDiagnostics & Research medianvs median
P/E31.1837.5917% below
P/S ratio4.175.2320% below
Profit margin13.44%−0.93%14.4 pts above

Medians across 45 Diagnostics & Research stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Sotera Health Company (SHC) is capitalised at $5.07B on the latest close. It is classified in the Diagnostics & Research industry, within the Healthcare sector. The company reports 3,000 employees.

SHC last closed at $17.77 on October 21, 2026. That is −$0.16 (−0.89%) against the previous close. The 52-week range on file runs from $13.09 to $19.85. The latest close sits 35.75% above that 52-week low.

Financial Health

In fiscal 2025, Sotera Health Company reported revenue of $1.16B. That is +5.74% against the prior fiscal year, when revenue was $1.10B. The same year closed with net income of $77.95M. That is +75.57% against the prior fiscal year. The reported profit margin is 13.44%. That is 14.4 percentage points above the Diagnostics & Research median of −0.93%. Trailing earnings per share are 0.57.

Across the 4 fiscal years on file, revenue moves from $1.00B in 2022 to $1.16B in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

SHC trades at a trailing price-to-earnings ratio of 31.18. That is 17.04% below the Diagnostics & Research median of 37.59. On forward earnings the ratio is 16.53. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.31. The price-to-sales ratio is 4.17. On price-to-sales that is 20.23% below the Diagnostics & Research median of 5.23. The medians here are taken across 45 Diagnostics & Research companies that report the metric.

Beta against the wider market is reported at 1.86. Annualized volatility over the trailing 5 years is 64.83%. Over the trailing twelve months the total return is +6.92%. Across 5 years the annualized return works out at −7.37%.

Growth & Income

The record shows no dividend for SHC.

2026 is still running; the total return is +0.74% year to date. Across the complete calendar years on file, 2023 returned +102.28% and 2022 returned −64.63%. Of the 5 complete calendar years on file, 2 finished higher.

Peer Comparison

Sotera Health Company (SHC) operates in the Diagnostics & Research industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Sotera Health Company SHC $5.07B 31.2
Thermo Fisher Scientific Inc. TMO $256.61B 37.4
Danaher Corporation DHR $164.40B 41.7
Natera, Inc. NTRA $59.59B —

The Diagnostics & Research industry average P/E ratio is 37.6x. Sotera Health Company trades at a P/E of 31.2.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Diagnostics & Research Stocks

TMO

Thermo Fisher Scientific Inc.

$256.61B

 DHR

Danaher Corporation

$164.40B

 NTRA

Natera, Inc.

$59.59B

 A

Agilent Technologies, Inc.

$50.12B

 IQV

IQVIA Holdings Inc.

$45.53B

 WAT

Waters Corporation

$44.92B
View all Diagnostics & Research stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Sotera Health Company

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Visit website →